Entogart is a Russian drug used in gastroenterology. It contains the active substance sodium gifenate and is intended for the treatment of liver and biliary tract diseases. Entogart has an antispasmodic, choleretic and hepatoprotective effect, improving metabolic processes in liver cells, stabilizing cell membranes and protecting them from toxic effects. The drug helps reduce bile stasis, facilitates digestion, which helps improve the general condition of patients with diseases of the liver, gallbladder and other related organs. It is indicated for chronic liver diseases, cholecystitis, biliary dyskinesia, but its use requires consultation with a doctor due to possible side effects such as allergies and dyspeptic disorders.